Botanix Pharmaceuticals Ltd
ASX:BOT
Botanix Pharmaceuticals Ltd
ASX:BOT
Price:
0.04
AUD
2.56%
Market Closed
Market Cap:
AU$88.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
AU |
|
I
|
Intervacc AB
STO:IVACC
|
SE |
|
H
|
Huazhang Technology Holding Ltd
HKEX:1673
|
CN |
|
Unimicron Technology Corp
TWSE:3037
|
TW |
|
CSI Properties Ltd
HKEX:497
|
HK |
|
F
|
Fujian Raynen Technology Co Ltd
SSE:603933
|
CN |
|
W
|
World Fuel Services Corp
F:WFK
|
US |
|
A
|
Aurora Solar Technologies Inc
F:A82
|
CA |
|
N
|
Nova Wellness Group Bhd
KLSE:NOVAMSC
|
MY |
|
Delivery Hero SE
LSE:0RTC
|
DE |
|
Gresham Technologies PLC
LSE:GHT
|
UK |
|
B
|
Baolingbao Biology Co Ltd
SZSE:002286
|
CN |
Balance Sheet
Balance Sheet Decomposition
Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Ltd
Balance Sheet Decomposition is not available for
Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Ltd
Balance Sheet
Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Ltd
Currency: AUD
| Jun-2002 | Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
3
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
4
|
6
|
17
|
5
|
25
|
22
|
7
|
10
|
79
|
65
|
|
| Cash |
3
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
6
|
17
|
5
|
25
|
22
|
7
|
10
|
79
|
65
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
1
|
28
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Current Assets |
3
|
1
|
2
|
2
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
4
|
6
|
18
|
5
|
25
|
22
|
11
|
14
|
83
|
100
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
11
|
29
|
28
|
|
| Goodwill |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
3
-35%
|
2
-17%
|
4
+51%
|
3
-32%
|
4
+39%
|
2
-32%
|
2
-15%
|
0
-97%
|
0
-33%
|
0
-50%
|
0
-50%
|
3
+25 400%
|
1
-48%
|
4
+180%
|
6
+60%
|
18
+200%
|
5
-71%
|
25
+387%
|
22
-13%
|
14
-36%
|
25
+77%
|
112
+353%
|
129
+15%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
4
|
1
|
1
|
6
|
2
|
3
|
12
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
0
|
0
|
1
|
0
|
1
|
5
|
1
|
1
|
6
|
2
|
4
|
25
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-37%
|
0
-38%
|
0
+39%
|
0
+12%
|
1
+114%
|
1
+80%
|
1
+6%
|
2
+63%
|
2
+22%
|
2
+4%
|
3
+7%
|
0
-88%
|
0
-70%
|
1
+463%
|
0
-9%
|
1
+203%
|
5
+222%
|
2
-63%
|
1
-31%
|
6
+412%
|
2
-68%
|
4
+98%
|
48
+1 181%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
37
|
37
|
38
|
69
|
8
|
12
|
13
|
16
|
17
|
18
|
20
|
21
|
26
|
26
|
5
|
12
|
33
|
34
|
71
|
71
|
71
|
93
|
188
|
226
|
|
| Retained Earnings |
33
|
35
|
36
|
65
|
6
|
10
|
12
|
15
|
19
|
20
|
22
|
24
|
23
|
24
|
2
|
6
|
17
|
33
|
48
|
51
|
63
|
71
|
80
|
146
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
4
N/A
|
3
-35%
|
2
-15%
|
3
+52%
|
2
-35%
|
3
+31%
|
1
-56%
|
1
-32%
|
2
N/A
|
2
-24%
|
2
-4%
|
3
-7%
|
2
N/A
|
1
-45%
|
3
+159%
|
5
+71%
|
16
+200%
|
1
-96%
|
24
+3 742%
|
21
-12%
|
8
-61%
|
23
+182%
|
109
+374%
|
81
-25%
|
|
| Total Liabilities & Equity |
5
N/A
|
3
-35%
|
2
-17%
|
4
+51%
|
3
-32%
|
4
+39%
|
2
-32%
|
2
-15%
|
0
-97%
|
0
-33%
|
0
-50%
|
0
-50%
|
3
+25 400%
|
1
-48%
|
4
+180%
|
6
+60%
|
18
+200%
|
5
-71%
|
25
+387%
|
22
-13%
|
14
-36%
|
25
+77%
|
112
+353%
|
129
+15%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
6
|
20
|
77
|
77
|
406
|
543
|
757
|
774
|
973
|
973
|
973
|
1 312
|
1 810
|
1 961
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
